Skip to main content

Utilization of Methotrexate: A Descriptive Analysis

    Basic Details
    Date Posted
    Status
    Complete
    Medical Product
    methotrexate
    Description

    In this report, we characterized utilization patterns of injectable methotrexate stratified by age, calendar month, cancer indication, and cancer indication and month in the Rapid Sentinel Distributed Database (SDD).

    The study period includes data from January 1, 2022 to December 31, 2023. We distributed this request to nine Sentinel Data Partners on February 5, 2024.

    Additional Details
    FDA Center
    CDER
    Time Period
    January 1, 2022 - December 31, 2023
    Analysis Type
    Descriptive
    Population / Cohort
    All individuals
    Data Sources
    Sentinel Distributed Database (SDD)